Eiji Kusumoto

Eiji Kusumoto

Auto-generated profile, based on publicly available information

Eiji Kusumoto

Department of Gastroenterological Surgery, Clinical Research Institute Cancer Research Division, National Kyushu Medical Center, Fukuoka, Japan.

Research Focus & Metrics

Academic Career Length

12Years (2015-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
20 February 2016 in Surgical Case Reports
Verified
Journal Article
Open access
PDF file
MSMasahiko Sugiyama
Masahiko Sugiyama
EKEiji Kusumoto
Eiji Kusumoto
MOMitsuhiko Ota
Mitsuhiko Ota
YKYasue Kimura
Yasue Kimura
NTNorifumi Tsutsumi
Norifumi Tsutsumi
YMYoshihiko Maehara
Yoshihiko Maehara
A 67-year-old man was diagnosed with rectal cancer. The tumor invaded the subserosal layer, but it was not large, and there was no sign of obstruction. Neo-adjuvant chemotherapy reduced the size of the tumor. The patient was admitted to our hospital for surgery. For mechanical bowel preparation, he ingested 34 g of magnesium citrate (Magcorol P®), but then developed severe shock, a disturbance of consciousness, and acidemia, and he required catecholamines and mechanical ventilation. X-ray, CT, and laboratory tests revealed ischemic colitis, toxic megacolon, and hypermagnesemia (16.3 mg/dL). After 2 days of temporary hemodialysis and an enema to reduce his blood magnesium concentration, he recovered and left the intensive care unit. However, the left side of his colon had suffered ischemic damage and become irreversibly atrophied. One month later, he underwent laparoscopic abdominoperineal resection and left-side colectomy for the rectal cancer and severe ischemic colitis of the left side of the colon. Histopathology confirmed the rectal cancer with a grade 2 chemotherapeutic effect and severe ischemic colitis of the left side of the colon. Hence, the present case suggests that severe ischemic colitis, toxic megacolon, and hypermagnesemia can occur after taking a magnesium laxative without obstruction of the intestine.

12 August 2015 in Surgical Case Reports
Verified
Journal Article
Open access
PDF file
EKEiji Kusumoto
Eiji Kusumoto
SYShohei Yamaguchi
Shohei Yamaguchi
MSMasahiko Sugiyama
Masahiko Sugiyama
MOMitsuhiko Ota
Mitsuhiko Ota
NTNorifumi Tsutsumi
Norifumi Tsutsumi
SMSeiya Momosaki
Seiya Momosaki
This report describes a patient with a rare huge epithelioid malignant peripheral nerve sheath tumor (MPNST) in the left axilla. A male in his 70s was admitted to our hospital for evaluation of a growing tumor in his left axilla. The tumor was solid and immovable. Examination of a biopsy specimen resulted in a diagnosis of epithelioid MPNST. Two weeks after the biopsy was performed, the tumor grew to 20 cm and became painful, and the patient was unable to feel pressure on his upper arm. Immediately before surgery to remove the tumor, computed tomography suggested the presence of lung metastases. The patient and his family were informed of his disease state, and they elected surgical treatment to ease the symptoms associated with tumor enlargement. Systemic metastases appeared soon after the surgery, and the patient died within 11 weeks. Comparative genomic hybridization (CGH) analysis showed that this tumor was chromosomally unstable, with impairments in gene expression.